Phase 2 Interstitial Lung Disease Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are 40 years old or older
• You have been diagnosed with idiopathic pulmonary fibrosis (IPF), a type of lung scarring disease, confirmed by a special type of CT scan called an HRCT
• Your CT scan shows a specific pattern of lung changes consistent with IPF, as confirmed by a central review team before the study begins
• You have previously received treatment for IPF that meets the study's specific requirements (confirm with trial site)
• Your lungs are working at 45% or more of the expected normal level, based on a breathing test called a Forced Vital Capacity (FVC) test
• You meet additional breathing test requirements at the screening visit (confirm with trial site)
• You have read about the trial, understood it, and have voluntarily agreed to take part by signing a consent form

Who may not be able to join:

• You have another condition that causes similar lung scarring patterns, such as rheumatoid arthritis-related or connective tissue disease-related lung disease, or other significant lung problems
• You have had a sudden, serious worsening of your IPF in the 6 months before screening or during the screening period
• You currently have a lower airway infection that needs antibiotic treatment
• You had major surgery in the 3 months before screening, or you have major surgery planned during the trial
• You have had cancer, or there is evidence of active or suspected cancer, within the past 5 years
• You currently have signs of an active infection
• You have had certain heart or blood vessel problems recently, including severe high blood pressure in the last 3 months, a heart attack or unstable chest pain in the last 6 months, a blood clot event in the last 6 months, or a heart failure diagnosis in the last 6 months
• You have high blood pressure in the lungs (pulmonary hypertension)
• You are unable to swallow tablets or capsules, or you have had major stomach or gut surgery, or have a digestive condition that might affect how the study drug is absorbed into your body
• You have HIV, or active hepatitis B or C

Important: Always verify eligibility with the trial site directly before applying.